Preparation, storage and quality control of platelet concentrates

Transfusion and Apheresis Science

Volumn 41, Issue 2, 2009, Pages 97-104

  Tynngård, Nahreen ^a  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; CITRATE SODIUM; CLORAZEPATE POTASSIUM; GLUCONATE SODIUM; HYPOTONIC SOLUTION; MAGNESIUM CHLORIDE; MANNITOL; SODIUM CHLORIDE; SODIUM DIHYDROGEN PHOSPHATE; THROMBOCYTE CONCENTRATE;

APHERESIS; ARTICLE; BACTEREMIA; BACTERIUM CONTAMINATION; BLEEDING TIME; BLOOD GAS; BLOOD PH; CARBON DIOXIDE TENSION; CITRIC ACID CYCLE; CONTAINER; GAMMA IRRADIATION; GLYCOLYSIS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; METABOLIC PARAMETERS; OXYGEN TENSION; QUALITY CONTROL; STORAGE TEMPERATURE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOCYTE LIFESPAN; THROMBOCYTE METABOLISM; THROMBOCYTE PRESERVATION; THROMBOCYTE RELEASE REACTION; THROMBOCYTE RICH PLASMA; THROMBOGENESIS; TRANSFUSION ASSOCIATED GRAFT VERSUS HOST DISEASE;

BLOOD PRESERVATION; HUMANS; PLATELET TRANSFUSION; PLATELETPHERESIS; QUALITY CONTROL;

EID: 70349159939     PISSN: 14730502     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transci.2009.07.001     Document Type: Article

References (106)

1. Murphy S., Sayar S.N., and Gardner F.H. Storage of platelet concentrates at 22 °C. Blood 35 (1970) 549-557
2. Snyder E.L., Koerner Jr. T.A., Kakaiya R., Moore P., and Kiraly T. Effect of mode of agitation on storage of platelet concentrates in PL-732 containers for 5 days. Vox Sang 44 (1983) 300-304
3. Snyder E.L., Bookbinder M., Kakaiya R., Ferri P., and Kiraly T. Five-day storage of platelet concentrates in CLX containers: effect of type of agitation. Vox Sang 45 (1983) 432-437
4. AuBuchon J.P., Taylor H., Holme S., and Nelson E. In vitro and in vivo evaluation of leukoreduced platelets stored for 7 days in CLX containers. Transfusion 45 (2005) 1356-1361
5. Dumont L.J., AuBuchon J.P., Whitley P., Herschel L.H., Johnson A., McNeil D., et al. Seven-day storage of single-donor platelets: recovery and survival in an autologous transfusion study. Transfusion 42 (2002) 847-854
6. Slichter S.J., and Harker L.A. Preparation and storage of platelet concentrates. II. Storage variables influencing platelet viability and function. Br J Haematol 34 (1976) 403-419
7. Murphy S., and Gardner F.H. Platelet storage at 22 °C: role of gas transport across plastic containers in maintenance of viability. Blood 46 (1975) 209-218
8. Baldini M., Costea N., and Dameshek W. The viability of stored human platelets. Blood 16 (1960) 1669-1692
9. Murphy S., and Gardner F.H. Effect of storage temperature on maintenance of platelet viability-deleterious effect of refrigerated storage. N Engl J Med 280 (1969) 1094-1098
10. Vassallo R.R., and Murphy S. A critical comparison of platelet preparation methods. Curr Opin Hematol 13 (2006) 323-330
11. Burgstaler E.A. Blood component collection by apheresis. J Clin Apher 21 (2006) 142-151
12. Holme S., Sweeney J.D., Sawyer S., and Elfath M.D. The expression of p-selectin during collection, processing, and storage of platelet concentrates: relationship to loss of in vivo viability. Transfusion 37 (1997) 12-17
13. Krailadsiri P., and Seghatchian J. Are all leucodepleted platelet concentrates equivalent? Comparison of Cobe LRS Turbo, Haemonetics MCS+ LD, and filtered pooled buffy-coat-derived platelets. Vox Sang 78 (2000) 171-175
14. Eriksson L., and Hogman C.F. Platelet concentrates in an additive solution prepared from pooled buffy coats. 1. In vitro studies. Vox Sang 59 (1990) 140-145
15. Murphy S., Heaton W.A., and Rebulla P. Platelet production in the Old World- and the New. Transfusion 36 (1996) 751-754
16. Gmur J., von Felten A., Osterwalder B., Honegger H., Hormann A., Sauter C., et al. Delayed alloimmunization using random single donor platelet transfusions: a prospective study in thrombocytopenic patients with acute leukemia. Blood 62 (1983) 473-479
17. Murphy S. Platelet storage for transfusion. Semin Hematol 22 (1985) 165-177
18. Gulliksson H. Defining the optimal storage conditions for the long-term storage of platelets. Transfus Med Rev 17 (2003) 209-215
19. Kilkson H., Holme S., and Murphy S. Platelet metabolism during storage of platelet concentrates at 22 °C. Blood 64 (1984) 406-414
20. Murphy S., Kahn R.A., Holme S., Phillips G.L., Sherwood W., Davisson W., et al. Improved storage of platelets for transfusion in a new container. Blood 60 (1982) 194-200
21. Simon T.L., Nelson E.J., Carmen R., and Murphy S. Extension of platelet concentrate storage. Transfusion 23 (1983) 207-212
22. Gulliksson H., Shanwell A., Wikman A., Reppucci A.J., Sallander S., and Uden A.M. Storage of platelets in a new plastic container. Polyvinyl chloride plasticized with butyryl-n-trihexyl citrate. Vox Sang 61 (1991) 165-170
23. Turner V.S., Mitchell S.G., Kang S.K., and Hawker R.J. A comparative study of platelets stored in polyvinyl chloride containers plasticised with butyryl trihexyl citrate or triethylhexyl trimellitate. Vox Sang 69 (1995) 195-200
24. Edenbrandt C.M., and Murphy S. Adenine and guanine nucleotide metabolism during platelet storage at 22 °C. Blood 76 (1990) 1884-1892
25. Guppy M., Whisson M.E., Sabaratnam R., Withers P., and Brand K. Alternative fuels for platelet storage: a metabolic study. Vox Sang 59 (1990) 146-152
26. Murphy S. The efficacy of synthetic media in the storage of human platelets for transfusion. Transfus Med Rev 13 (1999) 153-163
27. Cesar J., DiMinno G., Alam I., Silver M., and Murphy S. Plasma free fatty acid metabolism during storage of platelet concentrates for transfusion. Transfusion 27 (1987) 434-437
28. Moroff G., Friedman A., and Robkin-Kline L. Factors influencing changes in pH during storage of platelet concentrates at 20-24 °C. Vox Sang 42 (1982) 33-45
29. Holme S. Effect of additive solutions on platelet biochemistry. Blood Cells 18 (1992) 421-430
30. Murphy S., Shimizu T., and Miripol J. Platelet storage for transfusion in synthetic media: further optimization of ingredients and definition of their roles. Blood 86 (1995) 3951-3960
31. Rock G., and Figueredo A. Metabolic changes during platelet storage. Transfusion 16 (1976) 571-579
32. de Wildt-Eggen J., Nauta S., Schrijver J.G., van Marwijk Kooy M., Bins M., and van Prooijen H.C. Reactions and platelet increments after transfusion of platelet concentrates in plasma or an additive solution: a prospective, randomized study. Transfusion 40 (2000) 398-403
33. Gulliksson H. Storage of platelets in additive solutions: the effect of citrate and acetate in in vitro studies. Transfusion 33 (1993) 301-303
34. Gulliksson H., Eriksson L., Högman C.F., and Payrat J.M. Buffy-coat-derived platelet concentrates prepared from half-strength citrate CPD and CPD whole-blood units. Comparison between three additive solutions: in vitro studies. Vox Sang 68 (1995) 152-159
35. Lin L., Cook D.N., Wiesehahn G.P., Alfonso R., Behrman B., Cimino G.D., et al. Photochemical inactivation of viruses and bacteria in platelet concentrates by use of a novel psoralen and long-wavelength ultraviolet light. Transfusion 37 (1997) 423-435
36. Gulliksson H., Larsson S., Kumlien G., and Shanwell A. Storage of platelets in additive solutions: effects of phosphate. Vox Sang 78 (2000) 176-184
37. Gulliksson H., AuBuchon J.P., Vesterinen M., Sandgren P., Larsson S., Pickard C.A., et al. Storage of platelets in additive solutions: a pilot in vitro study of the effects of potassium and magnesium. Vox Sang 82 (2002) 131-136
38. Cardigan R., Sutherland J., Garwood M., Bashir S., Turner C., Smith K., et al. In vitro function of buffy coat-derived platelet concentrates stored for 9 days in CompoSol, PASII or 100% plasma in three different storage bags. Vox Sang 94 (2008) 103-112
39. Adams G.A., and Rock G. Storage of human platelet concentrates in an artificial medium without dextrose. Transfusion 28 (1988) 217-220
40. Ringwald J., Zimmermann R., and Eckstein R. The new generation of platelet additive solution for storage at 22 °C: development and current experience. Transfus Med Rev 20 (2006) 158-164
41. Brubaker D.B. Human posttransfusion graft-versus-host disease. Vox Sang 45 (1983) 401-420
42. Guidelines on gamma irradiation of blood components for the prevention of transfusion-associated graft-versus-host disease. BCSH blood transfusion task force. Transfus Med 1996;6:261-71.
43. Luban N.L., Drothler D., Moroff G., and Quinones R. Irradiation of platelet components: inhibition of lymphocyte proliferation assessed by limiting-dilution analysis. Transfusion 40 (2000) 348-352
44. Button L.N., DeWolf W.C., Newburger P.E., Jacobson M.S., and Kevy S.V. The effects of irradiation on blood components. Transfusion 21 (1981) 419-426
45. Moroff G., George V.M., Siegl A.M., and Luban N.L. The influence of irradiation on stored platelets. Transfusion 26 (1986) 453-456
46. Rock G., Adams G.A., and Labow R.S. The effects of irradiation on platelet function. Transfusion 28 (1988) 451-455
47. Slichter S.J., Davis K., Enright H., Braine H., Gernsheimer T., Kao K.J., et al. Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients. Blood 105 (2005) 4106-4114
48. Tynngård N., Studer M., Lindahl T.L., Trinks M., and Berlin G. The effect of gamma irradiation on the quality of apheresis platelets during storage for 7 days. Transfusion 48 (2008) 1669-1675
49. Kuehnert M.J., Roth V.R., Haley N.R., Gregory K.R., Elder K.V., Schreiber G.B., et al. Transfusion-transmitted bacterial infection in the United States, 1998 through 2000. Transfusion 41 (2001) 1493-1499
50. Lin L., Dikeman R., Molini B., Lukehart S.A., Lane R., Dupuis K., et al. Photochemical treatment of platelet concentrates with amotosalen and long-wavelength ultraviolet light inactivates a broad spectrum of pathogenic bacteria. Transfusion 44 (2004) 1496-1504
51. Stroncek D.F., and Rebulla P. Platelet transfusions. Lancet 370 (2007) 427-438
52. Knutson F., Alfonso R., Dupuis K., Mayaudon V., Lin L., Corash L., et al. Photochemical inactivation of bacteria and HIV in buffy-coat-derived platelet concentrates under conditions that preserve in vitro platelet function. Vox Sang 78 (2000) 209-216
53. McCullough J., Vesole D.H., Benjamin R.J., Slichter S.J., Pineda A., Snyder E., et al. Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial. Blood 104 (2004) 1534-1541
54. Grass J.A., Wafa T., Reames A., Wages D., Corash L., Ferrara J.L., et al. Prevention of transfusion-associated graft-versus-host disease by photochemical treatment. Blood 93 (1999) 3140-3147
55. Corash L., and Lin L. Novel processes for inactivation of leukocytes to prevent transfusion-associated graft-versus-host disease. Bone Marrow Transplant 33 (2004) 1-7
56. van Rhenen D.J., Vermeij J., Mayaudon V., Hind C., Lin L., and Corash L. Functional characteristics of S-59 photochemically treated platelet concentrates derived from buffy coats. Vox Sang 79 (2000) 206-214
57. Ciaravino V., McCullough T., and Dayan A. Pharmacokinetic and toxicology assessment of INTERCEPT (S-59 and UVA treated) platelets. Hum Exp Toxicol 20 (2001) 533-550
58. Apelseth T.O., Bruserud O., Wentzel-Larsen T., Bakken A.M., Bjorsvik S., and Hervig T. In vitro evaluation of metabolic changes and residual platelet responsiveness in photochemical treated and gamma-irradiated single-donor platelet concentrates during long-term storage. Transfusion 47 (2007) 653-665
59. Tynngård N., Johansson B.M., Lindahl T.L., Berlin G., and Hansson M. Effects of intercept pathogen inactivation on platelet function as analysed by free oscillation rheometry. Transfus Apher Sci 38 (2008) 85-88
60. Janetzko K., Lin L., Eichler H., Mayaudon V., Flament J., and Kluter H. Implementation of the INTERCEPT blood system for platelets into routine blood bank manufacturing procedures: evaluation of apheresis platelets. Vox Sang 86 (2004) 239-245
61. Snyder E., Raife T., Lin L., Cimino G., Metzel P., Rheinschmidt M., et al. Recovery and life span of 111indium-radiolabeled platelets treated with pathogen inactivation with amotosalen HCl (S-59) and ultraviolet A light. Transfusion 44 (2004) 1732-1740
62. van Rhenen D., Gulliksson H., Cazenave J.P., Pamphilon D., Ljungman P., Kluter H., et al. Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: the euroSPRITE trial. Blood 101 (2003) 2426-2433
63. Simonsen A.C., Johansson P.I., Conlan M.G., Jacquet M., Lin J.S., Junge K., et al. Transfusion of 7-day-old amotosalen photochemically treated buffy-coat platelets to patients with thrombocytopenia: a pilot study. Transfusion 46 (2006) 424-433
64. Slichter S.J., Raife T.J., Davis K., Rheinschmidt M., Buchholz D.H., Corash L., et al. Platelets photochemically treated with amotosalen HCl and ultraviolet A light correct prolonged bleeding times in patients with thrombocytopenia. Transfusion 46 (2006) 731-740
65. Murphy S., Snyder E., Cable R., Slichter S.J., Strauss R.G., McCullough J., et al. Platelet dose consistency and its effect on the number of platelet transfusions for support of thrombocytopenia: an analysis of the SPRINT trial of platelets photochemically treated with amotosalen HCl and ultraviolet A light. Transfusion 46 (2006) 24-33
66. Seghatchian J., and de Sousa G. Pathogen-reduction systems for blood components: the current position and future trends. Transfus Apher Sci 35 (2006) 189-196
67. Perez-Pujol S., Tonda R., Lozano M., Fuste B., Lopez-Vilchez I., Galan A.M., et al. Effects of a new pathogen-reduction technology (Mirasol PRT) on functional aspects of platelet concentrates. Transfusion 45 (2005) 911-919
68. AuBuchon J.P., Herschel L., Roger J., Taylor H., Whitley P., Li J., et al. Efficacy of apheresis platelets treated with riboflavin and ultraviolet light for pathogen reduction. Transfusion 45 (2005) 1335-1341
69. Picker S.M., Steisel A., and Gathof B.S. Effects of Mirasol PRT treatment on storage lesion development in plasma-stored apheresis-derived platelets compared to untreated and irradiated units. Transfusion 48 (2008) 1685-1692
70. Slichter S.J. Platelet transfusion therapy. Hematol Oncol Clin North Am 4 (1990) 291-311
71. Schlossberg H.R., and Herman J.H. Platelet dosing. Transfus Apher Sci 28 (2003) 221-226
72. Harker L.A., and Slichter S.J. The bleeding time as a screening test for evaluation of platelet function. N Engl J Med 287 (1972) 155-159
73. Rodgers R.P., and Levin J. A critical reappraisal of the bleeding time. Semin Thromb Hemost 16 (1990) 1-20
74. Dumont L.J., AuBuchon J.P., Gulliksson H., Slichter S.J., Elfath M.D., Holme S., et al. In vitro pH effects on in vivo recovery and survival of platelets: an analysis by the BEST collaborative. Transfusion 46 (2006) 1300-1305
75. Dumont L.J., and VandenBroeke T. Seven-day storage of apheresis platelets: report of an in vitro study. Transfusion 43 (2003) 143-150
76. Svendsen M.S., Rojkjaer R., Kristensen A.T., Salado-Jimena J.A., Kjalke M., and Johansson P.I. Impairment of the hemostatic potential of platelets during storage as evaluated by flow cytometry, thrombin generation, and thrombelastography under conditions promoting formation of coated platelets. Transfusion 47 (2007) 2057-2065
77. Holme S., Heaton W.A., and Courtright M. Platelet storage lesion in second-generation containers: correlation with platelet ATP levels. Vox Sang 53 (1987) 214-220
78. Sweeney J.D., Holme S., and Moroff G. Storage of apheresis platelets after gamma radiation. Transfusion 34 (1994) 779-783
79. Bertolini F., and Murphy S. A multicenter inspection of the swirling phenomenon in platelet concentrates prepared in routine practice. Biomedical excellence for safer transfusion (BEST) working party of the international society of blood transfusion. Transfusion 36 (1996) 128-132
80. 51Cr recovery in vivo of preserved platelets. Transfusion 14 (1974) 331-337
81. Okada Y., Maeno E., Shimizu T., Dezaki K., Wang J., and Morishima S. Receptor-mediated control of regulatory volume decrease (RVD) and apoptotic volume decrease (AVD). J Physiol 532 (2001) 3-16
82. Kim B.K., and Baldini M.G. The platelet response to hypotonic shock. Its value as an indicator of platelet viability after storage. Transfusion 14 (1974) 130-138
83. Michelson A.D., Barnard M.R., Krueger L.A., Frelinger III A.L., and Furman M.I. Evaluation of platelet function by flow cytometry. Methods 21 (2000) 259-270
84. Lindahl T.L., Festin R., and Larsson A. Studies of fibrinogen binding to platelets by flow cytometry: an improved method for studies of platelet activation. Thromb Haemost 68 (1992) 221-225
85. Schmitz G., Rothe G., Ruf A., Barlage S., Tschope D., Clemetson K.J., et al. European working group on clinical cell analysis: consensus protocol for the flow cytometric characterisation of platelet function. Thromb Haemost 79 (1998) 885-896
86. Fijnheer R., Modderman P.W., Veldman H., Ouwehand W.H., Nieuwenhuis H.K., Roos D., et al. Detection of platelet activation with monoclonal antibodies and flow cytometry. Changes during platelet storage. Transfusion 30 (1990) 20-25
87. Rinder H.M., Snyder E.L., Bonan J.L., Napychank P.A., Malkus H., and Smith B.R. Activation in stored platelet concentrates: correlation between membrane expression of P-selectin, glycoprotein IIb/IIIa, and beta-thromboglobulin release. Transfusion 33 (1993) 25-29
88. Leytin V., Allen D.J., Gwozdz A., Garvey B., and Freedman J. Role of platelet surface glycoprotein Ibalpha and P-selectin in the clearance of transfused platelet concentrates. Transfusion 44 (2004) 1487-1495
89. Turner C.P., Sutherland J., Wadhwa M., Dilger P., and Cardigan R. In vitro function of platelet concentrates prepared after filtration of whole blood or buffy coat pools. Vox Sang 88 (2005) 164-171
90. Metcalfe P., Williamson L.M., Reutelingsperger C.P., Swann I., Ouwehand W.H., and Goodall A.H. Activation during preparation of therapeutic platelets affects deterioration during storage: a comparative flow cytometric study of different production methods. Br J Haematol 98 (1997) 86-95
91. Tynngård N., Lindahl T.L., Trinks M., Studer M., and Berlin G. The quality of platelet concentrates produced by COBE Spectra and Trima Accel cell separators during storage for 7 days as assessed by in vitro methods. Transfusion 48 (2008) 715-722
92. Rinder H.M., and Smith B.R. In vitro evaluation of stored platelets: is there hope for predicting posttransfusion platelet survival and function?. Transfusion 43 (2003) 2-6
93. Rinder H.M., Murphy M., Mitchell J.G., Stocks J., Ault K.A., and Hillman R.S. Progressive platelet activation with storage: evidence for shortened survival of activated platelets after transfusion. Transfusion 31 (1991) 409-414
94. Rinder H.M., Bonan J.L., Rinder C.S., Ault K.A., and Smith B.R. Dynamics of leukocyte-platelet adhesion in whole blood. Blood 78 (1991) 1730-1737
95. Hoffmeister K.M., Felbinger T.W., Falet H., Denis C.V., Bergmeier W., Mayadas T.N., et al. The clearance mechanism of chilled blood platelets. Cell 112 (2003) 87-97
96. Slichter S.J., Bolgiano D., Jones M.K., Christoffel T., Corson J., Rose L., et al. Viability and function of 8-day-stored apheresis platelets. Transfusion 46 (2006) 1763-1769
97. Cardigan R., Turner C., and Harrison P. Current methods of assessing platelet function: relevance to transfusion medicine. Vox Sang 88 (2005) 153-163
98. Kattlove H.E., Alexander B., and White F. The effect of cold on platelets. II. Platelet function after short-term storage at cold temperatures. Blood 40 (1972) 688-696
99. Tynngård N., Lindahl T., Ramström S., and Berlin G. Effects of different blood components on clot retraction analysed by measuring elasticity with a free oscillating rheometer. Platelets 17 (2006) 545-554
100. Luddington R.J. Thrombelastography/thromboelastometry. Clin Lab Haematol 27 (2005) 81-90
101. Mallett S.V., and Cox D.J. Thrombelastography. Br J Anaesth 69 (1992) 307-313
102. Vig S., Chitolie A., Bevan D.H., Halliday A., and Dormandy J. Thromboelastography: a reliable test?. Blood Coagul Fibrinolysis 12 (2001) 555-561
103. Cammerer U., Dietrich W., Rampf T., Braun S.L., and Richter J.A. The predictive value of modified computerized thromboelastography and platelet function analysis for postoperative blood loss in routine cardiac surgery. Anesth Analg 96 (2003) 51-57
104. Gutensohn K., Geidel K., Kroeger N., Eifrig B., Crespeigne N., and Kuehnl P. Platelet function testing in apheresis products: flow cytometric, resonance thrombographic (RTG) and rotational thrombelastographic (roTEG) analyses. Transfus Apher Sci 26 (2002) 147-155
105. Reid T.J., Snider R., Hartman K., Greilich P.E., Carr M.E., and Alving B.M. A method for the quantitative assessment of platelet-induced clot retraction and clot strength in fresh and stored platelets. Vox Sang 75 (1998) 270-277
106. Rock G., Freedman M., Hamilton C., and Bormanis J. New methods showing in vitro changes of platelets. Transfus Apher Sci 35 (2006) 145-149